Noraxon, founded in 1987 and headquartered in the United States, is a stalwart in the biomechanics industry, providing advanced movement analysis technology. For over three decades, the company has supported researchers, clinicians, sports scientists, and ergonomists with precise, research-grade tools to capture and interpret human movement.
The company's ecosystem includes Surface EMG systems, 3D Motion Capture (IMUs), 2D Markerless Video, and Force & Pressure systems. These technologies are integrated into an all-in-one software platform, offering seamless data synchronization and workflow management. This makes Noraxon's solutions integral to universities, hospitals, and elite sports programs, as well as industries focused on ergonomics and product development.
Despite its established presence and technological advancements, it's important to note there has been no recent investment activity reported for Noraxon. This presents a potential opportunity for investors seeking to strengthen a core player in the biomechanics sector.